Moody's affirms 'A2' rating for University of Maryland Medical System

Moody's Investors Service affirmed its "A2" rating for the Baltimore-based University of Maryland Medical System, affecting $1.1 billion of outstanding debt.

The rating favorably acknowledges that the system's strong brand and leadership position, combined with its substantial geographic reach, will continue to lead to a notable market share and high patient demand. However, the rating will remain constrained by a modest balance sheet, a competitive operating environment and significant capital spending plans.

The rating outlook remains negative.

More articles on healthcare finance:

Utilities won't be shut off at Kansas hospital
California budget calls for healthcare spending boost
Bulk pricing of healthcare services saves time, money, business owner says

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Whitepapers

Featured Webinars